These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation. Bui HT, Krisnaswami A, Le CU, Chan J, Shenoy BN. Am J Cardiol; 2009 Nov 15; 104(10):1429-33. PubMed ID: 19892063 [Abstract] [Full Text] [Related]
6. The impact of pharmacist-managed oral anticoagulation therapy in older veterans. Poon IO, Lal L, Brown EN, Braun UK. J Clin Pharm Ther; 2007 Feb 15; 32(1):21-9. PubMed ID: 17286786 [Abstract] [Full Text] [Related]
9. Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic. Abdelhafiz AH, Wheeldon NM. Clin Ther; 2004 Sep 15; 26(9):1470-8. PubMed ID: 15531009 [Abstract] [Full Text] [Related]
10. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE, Rosenfeld LE, Mitrani G, Nemeth M, AFFIRM Investigators. Am Heart J; 2005 Apr 15; 149(4):650-6. PubMed ID: 15990748 [Abstract] [Full Text] [Related]
13. Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice. Abdelhafiz AH, Wheeldon NM. Am J Geriatr Pharmacother; 2008 Mar 15; 6(1):1-11. PubMed ID: 18396243 [Abstract] [Full Text] [Related]
14. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Douketis JD, Johnson JA, Turpie AG. Arch Intern Med; 2004 Jun 28; 164(12):1319-26. PubMed ID: 15226166 [Abstract] [Full Text] [Related]
15. Anemia, hypoalbuminemia, and renal impairment as predictors of bleeding complications in patients receiving anticoagulation therapy for nonvalvular atrial fibrillation: a secondary analysis. Abdelhafiz AH, Myint MP, Tayek JA, Wheeldon NM. Clin Ther; 2009 Jul 28; 31(7):1534-9. PubMed ID: 19695402 [Abstract] [Full Text] [Related]
16. Low-dose warfarin in atrial fibrillation leads to more thromboembolic events without reducing major bleeding when compared to adjusted-dose--a meta-analysis. Perret-Guillaume C, Wahl DG. Thromb Haemost; 2004 Feb 28; 91(2):394-402. PubMed ID: 14961170 [Abstract] [Full Text] [Related]
17. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials. Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL, SPORTIF Investigators. Am Heart J; 2006 Nov 28; 152(5):967-73. PubMed ID: 17070169 [Abstract] [Full Text] [Related]
18. [Anticoagulation in patients with atrial fibrillation]. Mügge A. Herz; 1996 Feb 28; 21(1):28-36. PubMed ID: 8647577 [Abstract] [Full Text] [Related]